[fusion_builder_container hundred_percent="no" equal_height_columns="no" menu_anchor="" hide_on_mobile="small-visibility,medium-visibility,large-visibility" class="" id="" background_color="" background_image="" background_position="center center" background_repeat="no-repeat" fade="no" background_parallax="none" parallax_speed="0.3" video_mp4="" video_webm="" video_ogv="" video_url="" video_aspect_ratio="16:9" video_loop="yes" video_mute="yes" overlay_color="" video_preview_image="" border_size="" border_color="" border_style="solid" padding_top="" padding_bottom="" padding_left="" padding_right=""][fusion_builder_row][fusion_builder_column type="1_1" layout="1_1" background_position="left top" background_color="" border_size="" border_color="" border_style="solid" border_position="all" spacing="yes" background_image="" background_repeat="no-repeat" padding_top="" padding_right="" padding_bottom="" padding_left="" margin_top="0px" margin_bottom="0px" class="" id="" animation_type="" animation_speed="0.3" animation_direction="left" hide_on_mobile="small-visibility,medium-visibility,large-visibility" center_content="no" last="no" min_height="" hover_type="none" link=""][fusion_text]
If you've been diagnosed with colorectal cancer or another type of cancer after long periods of Zantac use, you may have heard that the heartburn drug has been linked to several different forms of cancer. The FDA recently recalled Zantac and all forms of ranitidine due to a possible cancer-causing chemical in the drug. You could have grounds for a colorectal cancer lawsuit against Zantac manufacturers.
In December 2019, a California man named Gary Hart filed a lawsuit against Zantac manufacturers Boehringer Ingelheim, Sanofi US, Pfizer, and GlaxoSmithKline.
In the complaint, Hart says that he started using prescription Zantac in 200 and took 300 mg daily through 2008. In May 2008, he was diagnosed with colon cancer. Hart alleges that he developed his cancer due to Zantac's active ingredient, ranitidine, which may contain high levels of NDMA, increasing the risk of several types of cancers in the digestive system.
According to the lawsuit, the drug manufacturers knew or should have known that Zantac was linked to cancer, but failed to notify consumers, doctors, and regulators of this information.
In the early stages of colorectal cancer, symptoms may be minor or not present at all. In many cases, symptoms only develop after the cancer has reached stage II or later. This is why its important to have regular colonoscopies after age 50.
However, there are some early warning signs of colorectal cancer in some patients. Some of these warning signs include:
Some symptoms only affect the colon and/or rectum, including:
According to researchers, there are several risk factors that could increase your risk of developing colorectal polyps or colorectal cancer:
[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]